Emma Sandén

1.2k total citations
15 papers, 418 citations indexed

About

Emma Sandén is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Emma Sandén has authored 15 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Emma Sandén's work include Glioma Diagnosis and Treatment (5 papers), Immunotherapy and Immune Responses (3 papers) and Chemokine receptors and signaling (2 papers). Emma Sandén is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Immunotherapy and Immune Responses (3 papers) and Chemokine receptors and signaling (2 papers). Emma Sandén collaborates with scholars based in Sweden, Germany and Denmark. Emma Sandén's co-authors include Anna Darabi, Peter Siesjö, Edward Visse, Marcel Kool, Sara Fritzell, Cecilia Dyberg, John Inge Johnsen, Malin Wickström, Jelena Milosevic and Baldur Sveinbjørnsson and has published in prestigious journals such as Nature Communications, Scientific Reports and International Journal of Cancer.

In The Last Decade

Emma Sandén

15 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Sandén Sweden 10 208 143 125 113 92 15 418
Antonela S. Asad Argentina 12 216 1.0× 125 0.9× 129 1.0× 140 1.2× 65 0.7× 20 451
Alexander Ou United States 8 296 1.4× 138 1.0× 82 0.7× 55 0.5× 119 1.3× 14 495
Seon Yong Lee South Korea 10 188 0.9× 86 0.6× 101 0.8× 100 0.9× 89 1.0× 15 346
Berta Segura‐Collar Spain 11 156 0.8× 114 0.8× 91 0.7× 91 0.8× 56 0.6× 20 327
Drew Spencer United States 8 203 1.0× 142 1.0× 142 1.1× 42 0.4× 82 0.9× 9 405
Luana Abballe Italy 14 308 1.5× 74 0.5× 90 0.7× 52 0.5× 147 1.6× 28 483
Qiaowei He China 9 150 0.7× 84 0.6× 89 0.7× 47 0.4× 84 0.9× 13 336
Zhitao Zong China 7 102 0.5× 122 0.9× 99 0.8× 124 1.1× 60 0.7× 8 317
Amanda L. Rinkenbaugh United States 5 205 1.0× 49 0.3× 135 1.1× 61 0.5× 126 1.4× 9 366
Ştefana Oana Purcaru Romania 12 148 0.7× 105 0.7× 73 0.6× 30 0.3× 90 1.0× 24 342

Countries citing papers authored by Emma Sandén

Since Specialization
Citations

This map shows the geographic impact of Emma Sandén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Sandén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Sandén more than expected).

Fields of papers citing papers by Emma Sandén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Sandén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Sandén. The network helps show where Emma Sandén may publish in the future.

Co-authorship network of co-authors of Emma Sandén

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Sandén. A scholar is included among the top collaborators of Emma Sandén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Sandén. Emma Sandén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Sandén, Emma, Somayeh Khazaei, Dean P. Edwards, et al.. (2021). The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study. Frontiers in Oncology. 11. 642768–642768. 6 indexed citations
2.
Sandén, Emma, et al.. (2021). Digital Twin - an Exploratory Study on its Opportunities and Challenges from a Supply Chain Perspective. Lund University Publications Student Papers (Lund University). 1 indexed citations
3.
Sandén, Emma, Somayeh Khazaei, Signe Borgquist, et al.. (2020). Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 477(2). 317–320. 16 indexed citations
4.
Sandén, Emma, Somayeh Khazaei, Björn Nodin, et al.. (2020). Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis. Frontiers in Oncology. 10. 1278–1278. 4 indexed citations
5.
Sandén, Emma, Cecilia Dyberg, Cecilia Krona, et al.. (2017). Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation. Scientific Reports. 7(1). 46366–46366. 15 indexed citations
6.
Sandén, Emma, Edward Visse, Marcel Kool, et al.. (2016). Preoperative systemic levels of VEGFA, IL‐7, IL‐17A, and TNF‐β delineate two distinct groups of children with brain tumors. Pediatric Blood & Cancer. 63(12). 2112–2122. 14 indexed citations
7.
Sandén, Emma, Cecilia Dyberg, Cecilia Krona, et al.. (2015). Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas. Journal of Neuro-Oncology. 123(1). 1–13. 12 indexed citations
8.
9.
Wickström, Malin, Cecilia Dyberg, Jelena Milosevic, et al.. (2015). Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance. Nature Communications. 6(1). 8904–8904. 193 indexed citations
10.
11.
Fritzell, Sara, et al.. (2013). Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion. Cancer Immunology Immunotherapy. 62(9). 1463–1474. 41 indexed citations
12.
Fritzell, Sara, et al.. (2013). IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models. Journal of Neuroimmunology. 258(1-2). 91–95. 25 indexed citations
13.
Ohlsson, Lars, Christopher Exley, Anna Darabi, et al.. (2013). Aluminium based adjuvants and their effects on mitochondria and lysosomes of phagocytosing cells. Journal of Inorganic Biochemistry. 128. 229–236. 29 indexed citations
14.
Sandén, Emma, et al.. (2013). Intratumoral COX‐2 inhibition enhances GM‐CSF immunotherapy against established mouse GL261 brain tumors. International Journal of Cancer. 134(11). 2748–2753. 32 indexed citations
15.
Forslund, Ola, Emma Sandén, Linda Holmquist Mengelbier, et al.. (2013). Absence of epstein-barr and cytomegalovirus infection in neuroblastoma cells by standard detection methodologies. Pediatric Blood & Cancer. 60(9). E91–E93. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonela S. Asad Breakdown of academic impact, for papers by Alexander Ou Breakdown of academic impact, for papers by Seon Yong Lee Breakdown of academic impact, for papers by Berta Segura‐Collar Breakdown of academic impact, for papers by Drew Spencer Breakdown of academic impact, for papers by Luana Abballe Breakdown of academic impact, for papers by Qiaowei He Breakdown of academic impact, for papers by Zhitao Zong Breakdown of academic impact, for papers by Amanda L. Rinkenbaugh Breakdown of academic impact, for papers by Ştefana Oana Purcaru
Rankless by CCL
2026